Dr. Rohit Goyal is a Professor of Pharmacology and Controller of Examinations with a PhD from Punjab Technical University, Jalandhar (2011). He has over 18 years of teaching and research experience in Molecular Pharmacology, Neurobiology, and Natural Products. His research focuses on molecular and pre-clinical pharmacology, drug discovery, Alzheimer’s disease, lifestyle disorders, circadian rhythm, osteoporosis, and asthma. Dr. Goyal has published 75 research and review papers (SCOPUS), contributed book chapters, and filed eight patents. He has received extramural funding from agencies including DST-SERB, ICMR, HIMCOSTE, and NMHS. He has guided 46 postgraduate and 8 doctoral students and presented his work at international conferences in the UK, USA, Netherlands, Japan, Australia, and Singapore, earning multiple travel grants. He has been recognized with awards including the Dr. P.D. Sethi Memorial Award (2020) and Best Poster Award at the 103rd Indian Science Congress (2016). Dr. Goyal serves as associate editor and reviewer for several scientific journals, holds roles on university committees, and is a CPCSEA nominee for animal research oversight. He is a member of national and international organizations including BPS, FIP, AAPS, IPS, APTI, ISCA, WASET, and SPER.

Jaewon Jung is a doctoral student at the Section of Neuromedical Science, Institute of Natural Medicine, University of Toyama. Her research interests include skeletal muscle atrophy and cognitive function. Her current work focuses on investigating the impact of skeletal muscle atrophy on cognitive impairment in young mice.

Prof. Renu Agarwal is a Professor of Pharmacology and Associate Dean of Research, Innovation and Postgraduate Studies in SOM. She graduated from University of Rajasthan, India; did her postgraduation from Universiti Sains Malaysia and PhD from University of Delhi, India. Since the beginning of her professional career of more than 25 years, she has been deeply involved in academic and research activities. Ocular pharmacology and therapeutics is her research interest and she has been involved in investigations related to glaucoma, cataract, uveitis and diabetic retinopathy. She has also worked in the area of neuroprotection, development of drug delivery systems and pharmacovigilance. She has more than 125 publications to her credit including papers in high indexed journals and chapters in various books published by international publishers of high repute. She has an H-index of 32. She has been awarded with several National and University research grants and 8 PhD, 3 Professional Master’s and 4 MSc students have completed their work under her supervision. Currently she is supervising 6 PhD and 1 Master student. She has also been an invited speaker at various meetings both nationally and internationally.

Prof. Igor Iezhitsa is a dedicated researcher and academic with a strong foundation in pharmacology, currently serving as Professor of Pharmacology at the International Medical University (IMU), Malaysia. His academic journey began at Ural State University in Russia, where he studied human physiology with a focus on psychophysiology, and later earned both his Ph.D. and Doctor of Sciences degrees in pharmacology from Volgograd State Medical University. His research has consistently focused on the development of CNS drugs aimed at enhancing mental and physical performance. This early work laid the foundation for his expertise in experimental pharmacology and drug safety studies. In 2009, Prof. Iezhitsa joined Universiti Teknologi MARA (UiTM), Malaysia, where he led research in neuroprotection related to Alzheimer’s disease, stroke, and glaucoma, and established the Center for Neuroscience (NeuRon). Since 2020, he has been based at IMU, where he teaches pharmacology and leads the Research Initiative Group on Neuropharmacology & Neuroprotection. His current research, supported by more than 45 research grants, focuses on neuroprotection in stroke, Alzheimer’s disease, and retinal disorders. He investigates the therapeutic potential of compounds such as magnesium taurate, trans-resveratrol, tocotrienol-rich fraction, atorvastatin, and novel imidazobenzimidazole derivatives in protecting against retinal and corneal injury. His work also includes the development of advanced therapeutic strategies using liposomal and nanoparticle-based formulations for targeted drug delivery in stroke and glaucoma. Throughout his career, Prof. Iezhitsa has supervised more than 20 postgraduate and undergraduate students, including PhD candidates, contributing significantly to the training of future researchers in pharmacology and neuroscience. He has received several prestigious awards, including the ECNP Fellowship Award (2002) and the Russian Federation Government Prize for Science and Technology (2010). He is also a frequent speaker at national and international scientific meetings, having delivered invited presentations and symposium lectures at international conferences and regional workshops. He has published more than 110 papers in indexed journals and authored five books and book chapters.

He is Vice director of National Center for Pharmaceutical Screening and PI, Ph.D. supervisor in the Institute of Materia Medica, Chinese Academy of Medical Sciences. In 2004, he graduated from Peking university and got Ph.D. degree in Biophysics. He worked as postdoctoral fellow in department of pharmacology, National Center for Pharmaceutical Screening, Institute of Materia Medica, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China from 2004-2006. He worked as Research Associate, Medical scientist, Assistant professor, faculty in Case Western Reserve University, Cleveland, USA and John Wayne Cancer Institute, Los Angeles, USA. He was hired as professor in the National Center for pharmaceutical Screening in Institute of Materia Medica, Chinese Academy of Medical Sciences from 2015. Currently, he has published more than 140 peer-reviewed papers

Weverton Castro Coelho-Silva is a PhD student researcher at the University of São Paulo's Ribeirão Preto Medical School (FMRP-USP), specifically within the Department of Neuroscience and Behavior. His work focuses on neurobehavioral research, often highlighted within neuroscience and black in neuro communities. He holds a Master's degree.